Hydralazine Hydrochloride Injection
Product Images NDC 70518-3659

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 70518-3659). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is information about Hydralazine HCl, a medication available in 20mg/mL injection form in 1 mL vials. It is intended for intramuscular or intravenous use as a single-dose vial. The medication is labeled for prescription use only and the National Drug Code (NDC) is 70518-3659-01. The manufacturer is Fresenius Kabi located in Lake Zurich, IL. Storage instructions and contact details for repackaging are provided on the vial. For detailed instructions, refer to the package insert.*
FDA Label Image

Structure (Hyd0r 0001 01)

FDA Label Image

Mm3 (Hydralazine HCl 20mg mL 70518 3659 02)

Mm3 (Hydralazine HCl 20mg  mL 70518 3659 02)
This is information regarding Hydralazine HCl in a 20mg/mL injection form, provided in a 1mL single-dose vial for intramuscular or intravenous use. This medication is for prescription-only use (Rx Only) and has an NDC number 70518-3659-02. The manufacturer is Fresenius Kabi from Lake Zurich, IL. It is crucial to store this medication between 20-25°C (58-77°F) and follow package insert directions for use. Keep it out of children's reach. For expiry and lot details, refer to the package.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.